Nancy Hamel

Nancy Hamel

UNVERIFIED PROFILE

Are you Nancy Hamel?   Register this Author

Register author
Nancy Hamel

Nancy Hamel

Publications by authors named "Nancy Hamel"

Are you Nancy Hamel?   Register this Author

53Publications

1751Reads

25Profile Views

SWI/SNF-Compromised Cancers Are Susceptible to Bromodomain Inhibitors.

Cancer Res 2019 May 15;79(10):2761-2774. Epub 2019 Mar 15.

Departments of Oncology and Experimental Medicine, McGill University, Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-18-1545DOI Listing
May 2019

Atypical tuberous sclerosis complex presenting as familial renal cell carcinoma with leiomyomatous stroma.

J Pathol Clin Res 2018 07 13;4(3):167-174. Epub 2018 Jun 13.

Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cjp2.104
Publisher Site
http://dx.doi.org/10.1002/cjp2.104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065116PMC
July 2018

Impaired RASGRF1/ERK-mediated GM-CSF response characterizes CARD9 deficiency in French-Canadians.

J Allergy Clin Immunol 2016 Apr 29;137(4):1178-1188.e7. Epub 2015 Oct 29.

Infectious Disease Susceptibility Program, McGill University Health Centre (MUHC) and Research Institute-MUHC (RI-MUHC), Montreal, Quebec, Canada; Department of Human Genetics, McGill University, Montreal, Quebec, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2015.09.016DOI Listing
April 2016

Ovarian embryonal rhabdomyosarcoma is a rare manifestation of the DICER1 syndrome.

Hum Pathol 2015 Jun 5;46(6):917-22. Epub 2015 Mar 5.

Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3A 0G4; Lady Davis Institute, Segal Cancer Centre, Jewish General Hospital, Montreal, Quebec, Canada H3T 1E2; Department of Medical Genetics, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada H3H 2R9; Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada H2W 1S6. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2015.02.008DOI Listing
June 2015

A homozygous PMS2 founder mutation with an attenuated constitutional mismatch repair deficiency phenotype.

J Med Genet 2015 May 17;52(5):348-52. Epub 2015 Feb 17.

Program in Cancer Genetics, Departments of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada Department of Human Genetics, McGill University, Montreal, Quebec, Canada Department of Medical Genetics, McGill University Health Centre, Montreal, Quebec, Canada Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jmedgenet-2014-102934DOI Listing
May 2015

Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada.

Hered Cancer Clin Pract 2014 28;12(1):19. Epub 2014 Aug 28.

Program in Cancer Genetics, Departments of Oncology and Human Genetics, Gerald Bronfman Centre for Clinical Research in Oncology, McGill University, Montreal, QC, Canada ; Lady Davis Institute, Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC, Canada ; Department of Medical Genetics, McGill University Health Centre, Montreal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1897-4287-12-19DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163678PMC
September 2014

Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type.

Nat Genet 2014 May 23;46(5):438-43. Epub 2014 Mar 23.

1] Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada. [2] Department of Medical Genetics, Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada. [3] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [4] Department of Medical Genetics, Research Institute, McGill University Health Centre, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/ng.2931
Publisher Site
http://dx.doi.org/10.1038/ng.2931DOI Listing
May 2014

Germ-line deletion in DICER1 revealed by a novel MLPA assay using synthetic oligonucleotides.

Eur J Hum Genet 2014 Apr 25;22(4):564-7. Epub 2013 Sep 25.

1] Program in Cancer Genetics, Departments of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada [2] Lady Davis Institute, Segal Cancer Centre, Jewish General Hospital, Montreal, Quebec, Canada [3] The Research Institute, McGill University Health Centre, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ejhg.2013.215DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953921PMC
April 2014

Germ-line and somatic DICER1 mutations in a pleuropulmonary blastoma.

Pediatr Blood Cancer 2013 Dec 19;60(12):2091-2. Epub 2013 Jul 19.

Lady Davis Institute, Segal Cancer Centre, Jewish General Hospital, Montreal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24692DOI Listing
December 2013

Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer.

Cancer Discov 2013 Apr 26;3(4):399-405. Epub 2012 Dec 26.

Abramson Cancer Center, Department of Medicine, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6160, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-12-0421DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625496PMC
April 2013

Familial prostate cancer: the damage done and lessons learnt.

Nat Rev Urol 2013 Feb 15;10(2):116-22. Epub 2013 Jan 15.

Department of Medical Genetics, Research Institute of McGill University Health Centre, Montreal, QC H3G 1A4, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2012.257DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913476PMC
February 2013

Germline DICER1 mutation and associated loss of heterozygosity in a pineoblastoma.

J Med Genet 2012 Jul 20;49(7):417-9. Epub 2012 Jun 20.

Program in Cancer Genetics, Department of Oncology and Human Genetics, Gerald Bronfman Centre for Clinical Research in Cancer, McGill University 546 Pine Avenue West, Montreal, Quebec H2W 1S6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jmedgenet-2012-100898DOI Listing
July 2012

Acinic cell carcinoma of the retromolar trigone region: expanding the tumor phenotype in Cowden syndrome?

Fam Cancer 2011 Dec;10(4):691-4

Department of Radiation Oncology, Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10689-011-9472-8
Publisher Site
http://dx.doi.org/10.1007/s10689-011-9472-8DOI Listing
December 2011

Germline DICER1 mutations and familial cystic nephroma.

J Med Genet 2010 Dec 29;47(12):863-6. Epub 2010 Oct 29.

Program in Cancer Genetics, Department of Oncology, McGill University, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jmg.2010.081216DOI Listing
December 2010

A genome-wide analysis of loss of heterozygosity and chromosomal copy number variation in Proteus syndrome using high-density SNP microarrays.

J Hum Genet 2010 Sep 17;55(9):627-30. Epub 2010 Jun 17.

Department of Human Genetics, McGill University, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jhg.2010.70DOI Listing
September 2010

How old is this mutation? - a study of three Ashkenazi Jewish founder mutations.

BMC Genet 2010 May 14;11:39. Epub 2010 May 14.

Genetics and Genome Biology, Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2156-11-39DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889843PMC
May 2010

Relationship between angiotensin-converting enzyme gene polymorphism and body composition, functional performance, and blood biomarkers in advanced cancer patients.

Clin Cancer Res 2009 Apr 3;15(7):2442-7. Epub 2009 Mar 3.

McGill Nutrition and Performance Laboratory, McGill University Health Centre, McGill University, Montreal, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1720DOI Listing
April 2009

Mixed ovarian germ cell tumor in a BRCA2 mutation carrier.

Int J Gynecol Pathol 2007 Apr;26(2):160-4

Department of Human Genetics and Medicine, SMBD-Jewish General Hospital, McGill University, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.pgp.0000228142.52054.0fDOI Listing
April 2007

Analysis of PALB2/FANCN-associated breast cancer families.

Proc Natl Acad Sci U S A 2007 Apr 9;104(16):6788-93. Epub 2007 Apr 9.

Program in Cancer Genetics, Departments of Oncology and Human Genetics and Departments of Medicine and Human Genetics, McGill University, Montréal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0701724104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1871863PMC
April 2007

Risk of non-medullary thyroid cancer influenced by polymorphic variation in the thyroglobulin gene.

Carcinogenesis 2004 Mar 21;25(3):369-73. Epub 2003 Nov 21.

Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgh027DOI Listing
March 2004

The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer.

Cancer Res 2004 Feb;64(3):830-5

Program in Cancer Genetics and Department of Oncology, Research Institute of the McGill University Health Centre, and Cancer Prevention Centre, Sir M. B. Davis-Jewish General Hospital, McGill University, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.can-03-2970DOI Listing
February 2004

Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer.

BMC Med Genet 2003 Aug 11;4. Epub 2003 Aug 11.

Program in Cancer Genetics, Department of Oncology, McGill University, Montreal, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2350-4-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC194219PMC
August 2003